Results 101 to 110 of about 5,882 (203)

Immunoproteasomes [PDF]

open access: yes, 2012
Deborah A. Ferrington, Dale S. Gregerson
openaire   +2 more sources

Dysregulation of immunoproteasomes in autoinflammatory syndromes

open access: yesInternational Immunology, 2018
Abstract Immunoproteasomes degrade ubiquitin-coupled proteins and play a role in creating peptides for presentation by MHC class I proteins. Studies of gene-deficient mice, in which each immunoproteasomal subunit was affected, have demonstrated that dysfunction of immunoproteasomes leads to immunodeficiency, i.e.
openaire   +2 more sources

The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3

open access: yes, 2016
Cardiomyocyte death as a result of viral infection is an excellent model for dissecting the inflammatory stress response that occurs in heart tissue. We reported earlier that a specific proteasome isoform, the immunoproteasome, prevents exacerbation of ...
Antje Voigt   +21 more
core   +1 more source

Recent Advances in the Development of Immunoproteasome Inhibitors as Anti-Cancer Agents: The Past 5 Years

open access: yesMolecules
The immunoproteasome (iCP) is an isoform of the 20S proteasome that is expressed in response to cellular stress or inflammatory stimuli. The primary role of the iCP is to hydrolyze proteins into peptides that can be loaded into the MHC-I complex.
Francesca Mancuso   +5 more
doaj   +1 more source

Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2019
Proteasome inhibition is a promising strategy for the treatment of multiple myeloma; unfortunately, this disease is often associated with an increasing chemoresistance.
Roberta Ettari   +9 more
doaj   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Modified siRNA effectively silence inducible immunoproteasome subunits in NSO cells [PDF]

open access: yes, 2016
© 2016 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.The pathogenesis of autoimmune and neurodegenerative diseases involves overexpression of inducible subunits of the immunoproteasome. However, the
Belogurov A.   +8 more
core  

Modified siRNA effectively silence inducible immunoproteasome subunits in NSO cells

open access: yes, 2020
© 2016 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.The pathogenesis of autoimmune and neurodegenerative diseases involves overexpression of inducible subunits of the immunoproteasome. However, the
Belogurov A.   +8 more
core  

Heatmap illustration of immunoproteasome genes.

open access: yes, 2013
(A) The heatmap shows immunoproteasome genes (protein ubiquitinitation pathway) that were differentially expressed in monocytes from IFNb responders and non-responders. Gene names and Affymetrix probe sets are shown on the right part of the figure. Green
Marta F. Bustamante (208447)   +4 more
core   +1 more source

CGRPβ suppresses the pathogenesis of ulcerative colitis via the immunoproteasome

open access: yesScientific Reports
Various factors have been implicated in the pathogenesis of ulcerative colitis (UC), with immune system failure being the most important one. Calcitonin gene-related peptide (CGRP), a neuropeptide with two isoforms, CGRPα and CGRPβ, has been reported to ...
Tatsuya Shibao   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy